Validation of an Epigenetic Prognostic Assay to Accurately Risk-Stratify Patients With Barrett Esophagus. Laun SE, Kann L, Braun J, Gilbert S, et al. Am J Gastroenterol 2024;120:1296-1306.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Laun SE, Kann L, Braun J, Gilbert S, et al. Validation of an Epigenetic Prognostic Assay to Accurately Risk-Stratify Patients With Barrett Esophagus. Am J Gastroenterol 2024;120:1296-1306.
PMID: 39140473